Gene · 4781
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC01235 Is an Upstream Regulator of the NFIB Gene and the Notch Pathway in Triple-Negative Breast Cancer. | Mol Cancer Res | 2025 | 40586711 | PubTator, text mining | PubMed |
| Adenoid cystic carcinoma of the breast: Molecular profiling updates and multidimensional detection of MYB. | Pathol Res Pract | 2025 | 40580908 | PubTator, text mining | PubMed |
| Impact of the transcription factor nuclear factor 1 B T>C polymorphism on clozapine metabolism in vivo and expression of intestinal transporters in vitro. | Drug Metab Dispos | 2025 | 40554316 | PubTator, text mining | PubMed |
| Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer's disease. | Trends Neurosci | 2025 | 40506325 | PubTator, text mining | PubMed |
| Molecular advances in adenoid cystic carcinoma: Genetic and epigenetic insights. | Arch Oral Biol | 2025 | 40499274 | PubTator, text mining | PubMed |
| A Super-Enhancer-Driven Transcriptional Regulatory Circuit Underlying Abiraterone Resistance in Castration-Resistant Prostate Cancer. | Adv Sci (Weinh) | 2025 | 40470696 | PubTator, text mining | PubMed |
| Molecular heterogeneity of small cell lung cancer and new therapeutic possibilities: a narrative review of the literature. | Transl Lung Cancer Res | 2025 | 40386726 | PubTator, text mining | PubMed |
| scRNA-seq and scATAC-seq reveal that Sertoli cell mediates spermatogenesis disorders through stage-specific communications in non-obstructive azoospermia. | Elife | 2025 | 40371706 | PubTator, text mining | PubMed |
| Characterization of uniquely tumorigenic cancer stem cells in salivary gland adenoid cystic carcinoma. | Front Oral Health | 2025 | 40371051 | PubTator, text mining | PubMed |
| Discovering diabetes complications-related microRNAs: meta-analyses and pathway modeling approach. | BMC Med Genomics | 2025 | 40369506 | PubTator, text mining | PubMed |
| Discovering governing equations of biological systems through representation learning and sparse model discovery. | NAR Genom Bioinform | 2025 | 40290314 | PubTator, text mining | PubMed |
| Molecular pathology of adenoid cystic carcinoma. | Histol Histopathol | 2025 | 40254959 | PubTator, text mining | PubMed |
| Reversible downregulation of HLA class I in adenoid cystic carcinoma. | J Immunother Cancer | 2025 | 40254393 | PubTator, text mining | PubMed |
| Exploring potential treatment opportunities in a head and neck tumor patient with AdCC: A novel germline ERCC2 mutation case report. | Medicine (Baltimore) | 2025 | 40184085 | PubTator, text mining | PubMed |
| Cryo-EM of AKAP350/AKAP9 Reveals Fibrillar Clusters and an Association With DNA. | J Mol Biol | 2025 | 40154916 | PubTator, text mining | PubMed |
| Solid basaloid adenoid cystic carcinoma of the breast: A high-grade triple negative breast carcinoma which rarely responds to neoadjuvant chemotherapy. | Hum Pathol | 2025 | 40147795 | PubTator, text mining | PubMed |
| Complex G-protein signaling of the adhesion GPCR, ADGRA3. | J Biol Chem | 2025 | 40127866 | PubTator, text mining | PubMed |
| Deciphering Precursor Cell Dynamics in Esophageal Preneoplasia via Genetic Barcoding and Single-Cell Transcriptomics. | bioRxiv | 2025 | 40060545 | PubTator, text mining | PubMed |
| Characterization of moyamoya disease molecular subtypes through disulfidptosis‑related genes and immune landscape analysis. | Exp Ther Med | 2025 | 40012919 | PubTator, text mining | PubMed |
| A role for NFIB in SOX2 downregulation and epigenome accessibility changes due to long-term estrogen treatment of breast cancer epithelial cells. | Biochem Cell Biol | 2025 | 40009831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4781/papers?page=4